6 active not recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Active not recruiting 6 |
| Phase 2 | 2 | Active not recruiting 2 |
Follow Colitis: new trials by email Literature Review of Colitis trials Research Report on Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients Vitamin D3 (Cholecalciferol) - Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease) | Phase 1 | Active not recruiting | Terry Ponich | 150 | 2025-11-05 | 2026-10-05 |
| A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants GSK4528287, Placebo - Colitis, Ulcerative | Phase 1 | Active not recruiting | GlaxoSmithKline | 48 | 2024-11-18 | 2026-08-26 |
| CP101 for the Treatment of Ulcerative Colitis CP-101, CP-101 + Placebo - Ulcerative Colitis | Phase 1 | Active not recruiting | Brigham and Women's Hospital | 30 | 2023-09-01 | 2025-09-16 |
| Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder) | Phase 1 / Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 3 | 2022-06-10 | 2025-02-11 |
| Angiographic Delivery of AD-MSC for Ulcerative Colitis Adipose derived, autologous mesenchymal stem cells - Ulcerative Colitis | Phase 1 | Active not recruiting | Mayo Clinic | 20 | 2020-11-16 | 2026-01-21 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
Colitis, Ulcerative (5) · Inflammatory Bowel Diseases (3) · Crohn Disease (2) · Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus, Insulin-Dependent, 12 (1) · Melanoma (1) · Urogenital Neoplasms (1)
Colonic Diseases (6) · Digestive System Diseases (6) · Gastroenteritis (6) · Gastrointestinal Diseases (6) · Intestinal Diseases (6) · Inflammatory Bowel Diseases (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Lung Diseases (1) · Lung Neoplasms (1) · Male Urogenital Diseases (1) · Neoplasms (1)
CT-P13 (1) · Cholecalciferol (1) · Disulfides (1) · Hydroxychloroquine (1) · Immunoglobulin G (1) · Infliximab (1) · LDP-02 (1) · Mesalamine (1) · vedolizumab (1)
Brigham and Women's Hospital (1) · GlaxoSmithKline (1) · Icahn School of Medicine at Mount Sinai (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Terry Ponich (1)
United States (4) · Canada (1) · United Kingdom (1)
Judy H Cho, MD (1) · Subra Kugathasan, MD (1) · Terry P Ponich, MD, FRCPC (1) · William Faubion, MD (1) · Yinghong Wang (1)